Hunan Changsha Double Crane Pharmaceutical

China Resources Double Crane (Changsha) is a major pharmaceutical manufacturing subsidiary of China Resources Double Crane Pharmaceutical Co., Ltd., located in the Changsha Economic and Technological Development Zone. The company specializes in the production of large-volume parenterals (LVP), including intravenous infusions and electrolyte solutions, as well as a variety of oral solid dosage forms. Its therapeutic focus spans cardiovascular health, endocrinology, and anti-infectives, providing essential medicines such as amlodipine and gliclazide to the Chinese market. Operating under strict GMP standards, the facility serves as a critical production hub for the parent company's regional supply chain in Southern China. The company plays a vital role in the national essential drugs program, ensuring the availability of high-quality generic medications.